Page last updated: 2024-11-02

oxonic acid and Purpura, Thrombotic Thrombocytopenic

oxonic acid has been researched along with Purpura, Thrombotic Thrombocytopenic in 1 studies

Oxonic Acid: Antagonist of urate oxidase.

Purpura, Thrombotic Thrombocytopenic: An acquired, congenital, or familial disorder caused by PLATELET AGGREGATION with THROMBOSIS in terminal arterioles and capillaries. Clinical features include THROMBOCYTOPENIA; HEMOLYTIC ANEMIA; AZOTEMIA; FEVER; and thrombotic microangiopathy. The classical form also includes neurological symptoms and end-organ damage, such as RENAL FAILURE. Mutations in the ADAMTS13 PROTEIN gene have been identified in familial cases.

Research Excerpts

ExcerptRelevanceReference
"She was diagnosed with drug-induced thrombotic thrombocytopenic purpura (TTP)."1.39Drug-induced thrombotic thrombocytopenic purpura successfully treated with recombinant human soluble thrombomodulin. ( Fujimura, Y; Himeno, A; Hirata, H; Inoue, K; Kida, H; Kijima, T; Kumanogoh, A; Matsumoto, M; Nagatomo, I; Nishijima, Y; Otani, Y; Tachibana, I; Takahashi, R; Takeda, Y, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nishijima, Y1
Hirata, H1
Himeno, A1
Kida, H1
Matsumoto, M1
Takahashi, R1
Otani, Y1
Inoue, K1
Nagatomo, I1
Takeda, Y1
Kijima, T1
Tachibana, I1
Fujimura, Y1
Kumanogoh, A1

Other Studies

1 other study available for oxonic acid and Purpura, Thrombotic Thrombocytopenic

ArticleYear
Drug-induced thrombotic thrombocytopenic purpura successfully treated with recombinant human soluble thrombomodulin.
    Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:10

    Topics: Acute Kidney Injury; Antibodies, Monoclonal, Humanized; Antihypertensive Agents; Antineoplastic Comb

2013